Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma

NCT02899195 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Mesothelioma
Pleural Mesothelioma

Interventions

DRUG: Durvalumab

Sponsor

PrECOG, LLC.

Collaborators

[object Object]